All opinions my own and do not necessarily reflect those of Novo Nordisk
I was sitting around last evening checking out how the end of my fantasy baseball season is working out (for the record, first out of ten in one league and fourth in the league I wrote about here) and I starting thinking again about the parallels between baseball and drug development (which I previously wrote about here and here for example, and also Stewart Lyman has a nice piece on a similar theme here). And it hit me that there’s another way in which biopharma could take a page from baseball: fantasy and Major League Baseball both.
Biopharma could institute a draft for drug targets. And to explore this I’m going to employ the time-honored, not to mention trite and artificial, format of a series of questions and answers.